Supply of Pembrolizumab to University Hospital Brno for 4 years.
The University Hospital Brno is procuring the medicinal product with the active substance Pembrolizumab, used in oncology. The contract covers the supply of this specific pharmaceutical for a period of 4 years. The tender is open to all qualified suppliers who can provide the specified drug. The estimated value is not disclosed, but the duration suggests a significant commitment. Bidders must demonstrate ability to supply the product consistently.